Bone allografts are immunogenic and may preclude subsequent organ transplants.
The authors report a case of a 41-year-old woman with diabetes and chronic renal failure in whom antihuman leukocyte antigen antibodies developed after she received a frozen bone allograft that limited her access to organ donors. The patient had a chondrosarcoma of the right distal femur. A wide resection with segmental total knee arthroplasty was followed by a revision using a composite bone allograft prosthesis. After revision, broadly reactive lymphocytotoxic antibodies developed in the patient. The patient's panel reactive antibody level rose from 28% to a peak of 70%. Panel reactive antibody expresses the percentage of a panel of human leukocyte antigen type T lymphocytes from 40 individuals (representative of all human leukocyte antigen Class I histocompatibility antigens) to which antihuman leukocyte antigen Class I lymphocytotoxic antibodies have developed in the recipient as measured by the antiglobulin crossmatch method. The specificity of the patient's primary antibody is found in 45% of donors available in Illinois since 1988 (N = 1606). Because a positive crossmatch precludes kidney and pancreas transplantation, at least 45% of cadaver organ donors were excluded from use for this patient. This is an unusual case that focuses on the potential impact of bone allografts in patients who may need subsequent organ transplantation.
Lee
M Y
MY
Section of Orthopaedic Surgery, University of Chicago, IL, USA.
Finn
H A
HA
Lazda
V A
VA
Thistlethwaite
J R
JR
Simon
M A
MA
D000328:Adult; D016025:Bone Transplantation / Q000276:immunology*; D002813:Chondrosarcoma / Q000601:surgery*; D048909:Diabetes Complications; D005260:Female; D005266:Femoral Neoplasms / Q000601:surgery*; D006680:HLA Antigens; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications; D016030:Kidney Transplantation; D007720:Knee Prosthesis; D016035:Pancreas Transplantation; D018579:Patient Selection; D012086:Reoperation
D006680:HLA Antigens